|Articles|April 15, 2016
- Gastrointestinal Special Issue
- Volume 1
- Issue 1
Medical Illustration: Targeting HER2 in Gastric Cancer
Author(s)Erin Moore
For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.
Advertisement
ILLUSTRATION BY ERIN MOORE
ORIGINALLY PUBLISHED IN “GUT REACTION,” CURE WINTER 2009
*HER2 is also associated with breast cancer.
For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.
Articles in this issue
over 10 years ago
In Gastroesophageal Cancers, Better Prevention and Treatments Neededover 10 years ago
An Insight Into Gastric Cancers and Life Without a Stomachover 10 years ago
Changing Lives With ImmunotherapyAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
6 Cancer Drugs FDA Approved in August 2026 and What They Mean for You
2
New Therapies Bring ‘Wins’ to Small Cell Lung Cancer Treatment
3
Lung Cancer Survivor Shares Her Journey After a Stage 2B Diagnosis
4
Diagnosed With Ovarian Cancer at 15: 10 Things That Helped Brynn Forlizzi Through Treatment
5